Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- Prostate cancer (advanced): Zoladex 3.6 mg SC q28d OR 10.8 mg SC q12w
- Stage B2-C prostate (with flutamide + RT): One 3.6 mg depot → 28 days later one 10.8 mg depot; continue during RT
- Endometriosis: Zoladex 3.6 mg SC q28d × 6 months (women ≥18 y only)
- Endometrial thinning: 1-2 depots (3.6 mg), 4 weeks apart
- Advanced breast cancer: Zoladex 3.6 mg SC q28d long-term
- Route: Subcutaneous injection into anterior abdominal wall by HCP